<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    2510618
   </pmid>
   <datecreated>
    <year>
     1989
    </year>
    <month>
     11
    </month>
    <day>
     30
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1989
    </year>
    <month>
     11
    </month>
    <day>
     30
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0003-4932
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       210
      </volume>
      <issue>
       5
      </issue>
      <pubdate>
       <year>
        1989
       </year>
       <month>
        Nov
       </month>
      </pubdate>
     </journalissue>
     <title>
      Annals of surgery
     </title>
     <isoabbreviation>
      Ann. Surg.
     </isoabbreviation>
    </journal>
    <articletitle>
     Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients.
    </articletitle>
    <pagination>
     <medlinepgn>
      590-5
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      Bleeding from gastroduodenal lesions is a potentially life-threatening complication in patients subjected to overwhelming physiologic stress. Titration of gastric contents with antacid was the first prophylactic treatment regimen proved to decrease the incidence of bleeding and remains the standard by which other methods are compared. We designed a prospective double-blind, double-placebo study comparing the effectiveness of antacid titration with fixed doses of a synthetic prostaglandin E1 analog (misoprostol) for preventing stress gastritis and bleeding. To assess the success of each treatment regimen, we did endoscopic examinations before operation, 72 hours after operation, and after the patient had completed the study. A total of 281 patients entered the study (140 misoprostol, 141 antacid). The two groups were comparable with respect to preoperative parameters and type of operation. We found no statistically significant differences between the two treatment groups concerning upper gastrointestinal tract lesions or serious adverse effects. No clinically evident upper gastrointestinal hemorrhage occurred in either group. Mean gastric pH, measured at two-hour intervals during the initial 72 hours, was maintained at 4.0 or higher in both groups. We conclude that fixed-dose misoprostol is as effective as intensive antacid titration in preventing stress ulcers and bleeding in surgical ICU patients.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Zinner
      </lastname>
      <forename>
       M J
      </forename>
      <initials>
       MJ
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Rypins
      </lastname>
      <forename>
       E B
      </forename>
      <initials>
       EB
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Martin
      </lastname>
      <forename>
       L R
      </forename>
      <initials>
       LR
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Jonasson
      </lastname>
      <forename>
       O
      </forename>
      <initials>
       O
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Hoover
      </lastname>
      <forename>
       E L
      </forename>
      <initials>
       EL
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Swab
      </lastname>
      <forename>
       E A
      </forename>
      <initials>
       EA
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Fakouhi
      </lastname>
      <forename>
       T D
      </forename>
      <initials>
       TD
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Comparative Study
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Multicenter Study
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     UNITED STATES
    </country>
    <medlineta>
     Ann Surg
    </medlineta>
    <nlmuniqueid>
     0372354
    </nlmuniqueid>
    <issnlinking>
     0003-4932
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Antacids
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Anti-Ulcer Agents
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Drug Combinations
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      1309-42-8
     </registrynumber>
     <nameofsubstance>
      Magnesium Hydroxide
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      21645-51-2
     </registrynumber>
     <nameofsubstance>
      Aluminum Hydroxide
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      37317-08-1
     </registrynumber>
     <nameofsubstance>
      aluminum hydroxide, magnesium hydroxide, drug combination
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      59122-46-2
     </registrynumber>
     <nameofsubstance>
      Misoprostol
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      745-65-3
     </registrynumber>
     <nameofsubstance>
      Alprostadil
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Dig Dis Sci. 1988 Mar;33(3):298-302
     </refsource>
     <pmid version="1">
      3125026
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Dig Dis Sci. 1986 Feb;31(2 Suppl):47S-54S
     </refsource>
     <pmid version="1">
      3080288
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Intern Med. 1987 Apr;106(4):562-7
     </refsource>
     <pmid version="1">
      3548524
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Drugs. 1986 Nov;32(5):445-57
     </refsource>
     <pmid version="1">
      3792228
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Digestion. 1985;31(1):1-8
     </refsource>
     <pmid version="1">
      3979676
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Med. 1984 Apr;76(4):623-30
     </refsource>
     <pmid version="1">
      6608877
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Surg. 1969 Apr;117(4):523-30
     </refsource>
     <pmid version="1">
      5771525
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Surgery. 1980 Jul;88(1):59-68
     </refsource>
     <pmid version="1">
      6966835
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 1978 May 11;298(19):1041-5
     </refsource>
     <pmid version="1">
      25384
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Dig Dis. 1978 May;23(5):436-42
     </refsource>
     <pmid version="1">
      677095
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Surg. 1972 Apr;175(4):555-62
     </refsource>
     <pmid version="1">
      4553581
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Surg. 1971 Apr;102(4):266-73
     </refsource>
     <pmid version="1">
      5553299
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Surg Gynecol Obstet. 1981 Aug;153(2):214-20
     </refsource>
     <pmid version="1">
      7017982
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Alprostadil
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aluminum Hydroxide
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Antacids
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Anti-Ulcer Agents
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Critical Care
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Double-Blind Method
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Drug Combinations
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Hydrogen-Ion Concentration
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Magnesium Hydroxide
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Misoprostol
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Multicenter Studies as Topic
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Peptic Ulcer
     </descriptorname>
     <qualifiername majortopicyn="N">
      etiology
     </qualifiername>
     <qualifiername majortopicyn="Y">
      prevention &amp; control
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Postoperative Complications
     </descriptorname>
     <qualifiername majortopicyn="N">
      prevention &amp; control
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Prospective Studies
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Randomized Controlled Trials as Topic
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Stress, Physiological
     </descriptorname>
     <qualifiername majortopicyn="Y">
      complications
     </qualifiername>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1357791
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1989
     </year>
     <month>
      11
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2000
     </year>
     <month>
      6
     </month>
     <day>
      1
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1989
     </year>
     <month>
      11
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     2510618
    </articleid>
    <articleid idtype="pmc">
     PMC1357791
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

